GlassScriptPhysician profile
John W Royalty
NPI 1649274259
$2,642.45
in general payments reported to CMS, 2019-2025
9 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.32 · 2020: $15.47 · 2021: $83.57 · 2022: $81.83 · 2023: $96.08 · 2024: $2,162 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,410 · Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,409.97 |
| Food and Beverage | $1,005.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $1,529.52 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $637.04 | 2022-2024 | Endurant Iis |
| Penumbra, INC. | $164.87 | 2024-2025 | Penumbra System, Indigo System, Ruby Coil |
| Boston Scientific Corporation | $111.35 | 2019-2025 | Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $83.16 | 2019-2022 | |
| Olympus Corporation of The Americas | $49.12 | 2025 | Itind System |
| Medtronic Vascular, INC. | $31.47 | 2019-2020 | |
| Pfizer INC. | $20.27 | 2024 | |
| Ambu INC. | $15.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Royalty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.